Burning Rock Biotech
18 hedge funds and large institutions have $9.65M invested in Burning Rock Biotech in 2025 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 8 reducing their positions, and 3 closing their positions.
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
0.26% less ownership
Funds ownership: 2.85% → 2.59% (-0.26%)
14% less funds holding
Funds holding: 21 → 18 (-3)
39% less capital invested
Capital invested by funds: $15.8M → $9.65M (-$6.19M)
88% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 8
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$25 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CL
CRCM LP
San Francisco,
California
|
-$622K |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$82.8K |
| 3 |
NAMA
Nikko Asset Management Americas
New York
|
-$48.2K |
| 4 |
Sumitomo Mitsui Trust Group
Minato-Ku, Tokyo,
Japan
|
-$48.2K |
| 5 |
Massachusetts Financial Services
Boston,
Massachusetts
|
-$33.6K |
BNR Hedge Fund Activity: Q1 2025 in Review
18 of the 7,458 institutional investors tracked by Wall St. Rank reported a position in Burning Rock Biotech (BNR) for Q1 2025, worth a combined $9.65M — down 39% from $15.8M a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of BNR and 0 opened new positions — a net loss of 3 holders — while 8 trimmed existing stakes and 1 added.
The largest buyer was BlackRock, adding an estimated $25. The largest seller was CRCM LP, cutting an estimated $622K.
- 18 institutional investors held Burning Rock Biotech (BNR) as of Q1 2025, down from 21 in Q4 2024.
- Funds reported $9.65M of Burning Rock Biotech stock for Q1 2025, down 39% quarter-over-quarter.
- 0 funds opened new Burning Rock Biotech positions in Q1 2025 and 3 closed out, a net change of -3 holders.
- The largest Burning Rock Biotech buyer in Q1 2025 was BlackRock, an estimated $25 added.
- The largest Burning Rock Biotech seller in Q1 2025 was CRCM LP, an estimated $622K sold.
Based on aggregated 13F filings for Q1 2025.